Efficacy of alogliptin in type 2 diabetes treatment: a meta-analysis of randomized double-blind controlled studies
about
Safety of dipeptidyl peptidase 4 inhibitors: a perspective reviewEmerging options for the treatment of type 2 diabetes in Chinese patients: focus on arterial function and alogliptinAlogliptin benzoate for management of type 2 diabetesA Systematic Review of Methods for Handling Missing Variance Data in Meta-Analyses of Interventions in Type 2 Diabetes Mellitus.A comparison of effects of DPP-4 inhibitor and SGLT2 inhibitor on lipid profile in patients with type 2 diabetes.Clinical utility of dipeptidyl peptidase-4 inhibitors: a descriptive summary of current efficacy trials.Efficacy and Safety of Alogliptin in Patients With Type 2 Diabetes: Analysis of the ATTAK-J Study.Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitis.Alogliptin benzoate for the treatment of type 2 diabetes.Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes.Tight glycemic control and cardiovascular effects in type 2 diabetic patients.Alogliptin: a review of its use in patients with type 2 diabetes mellitus.DPP-4 inhibitors and risk of infections: a meta-analysis of randomized controlled trials.Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials.Alogliptin: a new dipeptidyl peptidase-4 inhibitor with potential anti-atherogenic properties.
P2860
Q26863262-724AA5B8-E1B0-43D9-98E7-4C20643467C1Q27008952-01D13B73-FBAC-4104-897C-FA0B929355DEQ28083933-B5DAB659-347C-4DC2-A812-9C8CD465981AQ31137238-63D8C6F7-CBFF-46A6-9749-BB8E9C695E0BQ33560279-407B48B2-E487-4F80-85E7-9FAEFA6CBE77Q35236019-9A1E508A-4C18-4457-B13A-9DFA4C891A40Q36429742-782F0164-0845-463E-94E9-3E19637F8FE3Q38101993-63BB46B2-3647-4184-A47D-846E6A87B8E8Q38197275-532BC8FB-7F46-48ED-B319-27BB9C9E2E0FQ38335751-E6DEE929-41A7-4003-B10F-A97DDFE1757DQ38379445-CFB495E7-0979-4C4A-81B5-2361A372F98FQ38412153-C681E18B-A456-41BF-BE8A-43B76DDAB55BQ40487459-E32BB86B-B7A1-41DE-952C-BBAF68079E98Q41422603-C1E513E7-18B5-49FC-B94C-90A796C23730Q51316002-5482AD78-0477-443F-84CF-1F2C681FD809
P2860
Efficacy of alogliptin in type 2 diabetes treatment: a meta-analysis of randomized double-blind controlled studies
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Efficacy of alogliptin in type ...... ouble-blind controlled studies
@ast
Efficacy of alogliptin in type ...... ouble-blind controlled studies
@en
Efficacy of alogliptin in type ...... ouble-blind controlled studies
@en-gb
Efficacy of alogliptin in type ...... ouble-blind controlled studies
@nl
type
label
Efficacy of alogliptin in type ...... ouble-blind controlled studies
@ast
Efficacy of alogliptin in type ...... ouble-blind controlled studies
@en
Efficacy of alogliptin in type ...... ouble-blind controlled studies
@en-gb
Efficacy of alogliptin in type ...... ouble-blind controlled studies
@nl
prefLabel
Efficacy of alogliptin in type ...... ouble-blind controlled studies
@ast
Efficacy of alogliptin in type ...... ouble-blind controlled studies
@en
Efficacy of alogliptin in type ...... ouble-blind controlled studies
@en-gb
Efficacy of alogliptin in type ...... ouble-blind controlled studies
@nl
P2860
P3181
P356
P1476
Efficacy of alogliptin in type ...... ouble-blind controlled studies
@en
P2093
Asres Berhan
Yifru Berhan
P2860
P2888
P3181
P356
10.1186/1472-6823-13-9
P407
P577
2013-01-01T00:00:00Z
P5875
P6179
1040686283